Core Laboratories Inc. (CLB) stock
CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3011% above fair value
$9.01−0.03 (-0.33%)
Close on Nov 12, 2026Market cap $412.87MP/E 26.5Yield 0.44%
Core Laboratories gross margin
Gross margin is gross profit as a percentage of revenue.
Core Laboratories's gross margin for the twelve months ending Sep 30, 2026 was 19.1%. For fiscal 2025 it was 20.7%, against 19.7% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.7% | +1.0 |
| FY2024 | Dec 31, 2024 | 19.7% | −1.8 |
| FY2023 | Dec 31, 2023 | 21.5% | +1.9 |
| FY2022 | Dec 31, 2022 | 19.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 20.4% | −1.6 |
| Q2 FY2026 | Jun 30, 2026 | 18.6% | −1.7 |
| Q1 FY2026 | Mar 31, 2026 | 16.2% | −3.3 |
| Q4 FY2025 | Dec 31, 2025 | 20.8% | +3.0 |
| Q3 FY2025 | Sep 30, 2025 | 22.0% | +1.5 |
| Q2 FY2025 | Jun 30, 2025 | 20.3% | −0.8 |
| Q1 FY2025 | Mar 31, 2025 | 19.5% | +0.2 |
| Q4 FY2024 | Dec 31, 2024 | 17.8% | – |
| Q3 FY2024 | Sep 30, 2024 | 20.5% | – |
| Q2 FY2024 | Jun 30, 2024 | 21.2% | – |
| Q1 FY2024 | Mar 31, 2024 | 19.3% | – |
See a number that looks wrong?